Austar Lifesciences Limited
AULSF
$0.02
-$0.05-71.43%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 621.10K | 615.20K | 1.73M | 1.72M | 709.10K |
| Total Depreciation and Amortization | 1.49M | 1.48M | 1.53M | 1.52M | 1.74M |
| Total Amortization of Deferred Charges | 196.30K | 194.40K | 215.80K | 214.50K | 201.00K |
| Total Other Non-Cash Items | 1.58M | 1.57M | -781.30K | -776.70K | 1.19M |
| Change in Net Operating Assets | 2.68M | 2.66M | -- | -- | 1.67M |
| Cash from Operations | 6.57M | 6.51M | 2.69M | 2.68M | 5.51M |
| Capital Expenditure | -833.80K | -825.80K | -780.20K | -775.60K | -1.04M |
| Sale of Property, Plant, and Equipment | 16.40K | 16.20K | -- | -- | 137.60K |
| Cash Acquisitions | -- | -- | -- | -- | 196.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.30K | 97.40K | 589.60K | 586.10K | 152.40K |
| Cash from Investing | -719.10K | -712.20K | -190.60K | -189.50K | -550.50K |
| Total Debt Issued | 116.02M | 116.02M | 78.85M | 78.85M | 80.85M |
| Total Debt Repaid | -122.22M | -122.22M | -94.59M | -94.59M | -99.57M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.65M | -3.65M | -3.36M | -3.36M | -3.94M |
| Cash from Financing | -1.39M | -1.38M | -2.64M | -2.63M | -3.15M |
| Foreign Exchange rate Adjustments | -35.90K | -35.60K | -10.10K | -10.00K | 55.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.42M | 4.38M | -148.10K | -147.20K | 1.86M |